Replies to post #316 on Quanta Inc (fka QNTA)

[No1Uknow]

Medolife Rx to Present at The 2021 Sequire Cannabis Conference on Tuesday, April 20, at 3 p.m. EST/12 p.m. PST

BURBANK, Calif., April 15, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated bioceutical company with R&D, manufacturing, and consumer product distribution, which is a majority owned subsidiary of Quanta, Inc. (OTC PINK: QNTA), announced today that Quanta’s President and Director Philip Sands will be presenting virtually at a cannabis investing conference, the 2021 Sequire Cannabis Conference, on Tuesday, April 20, at 3 p.m. EST/12 p.m. PST.

Sands will discuss how Medolife Rx and Quanta will continue to develop their positions in the bioceutical space. He will further discuss their cutting-edge technology, pharmaceutical research, and the development of consumer wellness products for the CBD industry. Additionally, he will address how the Company is planning to develop pharmaceutical-grade CBD products lines for which it will seek clinical regulatory approvals, focusing on indications such as pain.